Across TCGA pan-cancer cohorts, NBEAP4 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of NBEAP4’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where NBEAP4 RNA is repressed in tumor relative to normal tissue. In most cancer types NBEAP4 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
THCA are the cancer types where NBEAP4 tumor–normal differential expression is most reproducible.